Skip to content

Safety and Efficacy of Combined Anesthesia with High-Flow Nasal Oxygen for Painless Gastroscopy in High-Risk Patients in High-Altitude Areas

Safety and Efficacy of Combined Anesthesia with High-Flow Nasal Oxygen for Painless Gastroscopy in High-Risk Patients at High Altitude

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129493
Enrollment
Unknown
Registered
2026-08-05
Start date
2026-08-10
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless gastroscopy in high-risk populations in a high-altitude hypoxic environment

Interventions

Group A: Combined Anesthesia with Conventional Nasal Oxygen :Lidocaine Aerosol Inhalation + Remifentanil + Etomidate + Conventional Nasal Cannula Oxygen Therapy
Group B: Combined Anesthesia with High-Flow Nasal Oxygen :Lidocaine Aerosol Inhalation + Remifentanil + Etomidate + High-Flow Nasal Oxygen (HFNC)

Sponsors

People's Hospital of Hainan Tibetan Autonomous Prefecture, Qinghai Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 - 80 years. 2.Long-term residents of high-altitude regions (altitude >= 2500 m) who meet at least one of the following high-risk conditions: COPD; OSA; obesity (BMI =>=28 kg/m²); aged >= 60 years; 3.Informed consent: able to understand the study content and sign written informed consent.

Exclusion criteria

Exclusion criteria: 1.Acute coronary syndrome, decompensated heart failure (NYHA class IV), or uncontrolled severe arrhythmias. 2.Acute respiratory failure, acute respiratory infection, end-stage pulmonary disease, active asthma exacerbation, acute exacerbation of COPD, high-altitude pulmonary edema, or acute high-altitude illness. 3.Hepatic failure or decompensated liver disease; end-stage renal disease or renal failure requiring dialysis. 4.Active upper gastrointestinal bleeding, high-risk esophageal/gastric variceal bleeding, gastric emptying disorders, or high aspiration risk precluding non-intubated anesthesia. 5.History of allergy to anesthetics or medications (e.g., propofol, etomidate, remifentanil) or to high-flow nasal oxygen devices. 6.Pregnant or lactating women. 7.Concurrent participation in other clinical studies that may interfere with the results of this study. 8.Other conditions judged by the investigator to be unsuitable for participation.

Design outcomes

Primary

MeasureTime frame
Incidence of Hypoxemia;

Secondary

MeasureTime frame
Incidence of Severe Hypoxemia;Incidence of Airway Interventions;

Countries

China

Contacts

Public ContactLiu Lifeng

People's Hospital of Hainan Tibetan Autonomous Prefecture, Qinghai Province

342933120@qq.com+86 974 8522702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026